| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |